Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02278185
Title Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

prostate cancer

Therapies

Goserelin

Degarelix

Histrelin acetate

Triptorelin

Leuprolide

Enzalutamide

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
University of Colorado Health - Poudre Valley Hospital Fort Collins Colorado 80524 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field